You have underscored that one of the problems with IPIX is accurate reporting. As for Menon, In the 10-Q for the period ending September 30,2018, the company reported that Menon's employment was terminated. In a December filing, they changed it to his having resigned. In any event, a major player in the company's history is gone.
As for the $19,000 a month being a drop in the bucket, that may be true if your bucket is full of cash. But according to the 10-Q, IPIX has .03 million in cash and 8.3 million in liabilities. So hopefully they are putting that space to good use. And it stated in the 10-Q that "The Company believes, however, that if we are successful with advancing our Brilacidin Oral Mucositis and/or Prurisol Psoriasis programs into confirmatory studies, we will need all, or most of, the space as we could save substantial monies by doing in house functions that would otherwise be outsourced to contract research organizations. In the interim, we are planning to sublet laboratory space as we are now focused on conducting clinical studies." Maybe they will and maybe they won't use all of that space. But since P failed and is wiped off the face of the website, hopefully they will sublet half of the space to save some much needed money.
News 
Market Data 
Discover 
